BSE filing, NSE: SUNTECHNO. Summary written from the filing by ALFA Finder's alert engine.
Biogen Pharmachem Industries Ltd: key numbers
- Share price
- ₹0.25
- Market cap
- ₹26.33 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.86 Cr
- P/E (TTM)
- -158.2×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biogen Pharmachem Industries Ltd
All →Biogen Pharmachem Industries Board Meeting Date
Biogen Pharmachem Industries Ltd intimated a board meeting on 3 November 2026 to approve unaudited results for Q2 and half year ended 30 September 2026. The filing is a meeting notice only, with no monetary event.
Biogen Pharmachem Industries Other Announcement
Biogen Pharmachem Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI Regulation 31(1)(b).
Biogen Pharmachem Industries Annual General Meeting
Biogen Pharmachem Industries Limited held its 31st Annual General Meeting on 29th September 2026. Shareholders approved financial statements, director re-appointment, and the auditor appointment.
Biogen Pharmachem Industries Annual Report
Biogen Pharmachem Industries Limited submitted its 31st Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 29, 2026.
Biogen Pharmachem Industries Annual General Meeting
Biogen Pharmachem Industries Ltd has issued a notice for its 31st Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Biogen Pharmachem Industries Other Announcement
Biogen Pharmachem Industries Limited has reported no unutilised funds from any prior capital raises, including public issues, rights issues, or preferential allotments, as of June 2026.
Other capital structure change announcements
All →Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Blue Chip Tex Industries Capital Structure Change
Counter Cyclical Investments PMS sold 2,986 shares (0.15%) of Blue Chip Tex via open market, reducing its stake from 5.62% to 5.46%. The filing is a non-promoter SAST Reg 29(2) disclosure.
Swiggy Capital Structure Change
Nippon India Mutual Fund bought about 0.18% of Swiggy, lifting its stake from 4.99% to 5.17%. The disclosure is a non-promoter Reg 29(1) filing covering open-market purchases through October 26, 2026.
- Execution
- Purchase transactions from November 13, 2024 to October 26, 2026
Mahindra Logistics Capital Structure Change
Nippon India Mutual Fund sold 13.76 lakh Mahindra Logistics shares, cutting its stake to 3.05%. The non-promoter disposal was made via open market.